Abstract Submissions Rules

+++Submissions are accepted from 16th March to 4th May 2021+++

Please stick to the following Submission Rules:

  • all abstracts must be submitted online via the online Submission System
  • you need to enter the Submission System with your personal account
  • your abstract must be related to one main Category (bold) and one Subcategory as listed below* (In case no subcategory is listed your abstract must be submitted through the main category).
  • size limit: all in all 2850 characters (incl. space characters); divided into:
  • Introduction: 600
  • Methods: 800
  • Results/Discussion: 1000
  • Conclusion: 450
  • you strictly have to follow the scheme: Introduction, Methods, Results, Conclusions, Acknowledgement, References
  • you can add a maximum of two figures/pictures (jpeg, png) each with a limited size file of 2MB
  • Submissions as PRESENTING AUTHOR are limited to TWO (there is no limitation for co-authorship!)
  • you will be able to make changes on your submission until the submission deadline4th May 2021
  • all abstracts will be acknowledged upon receipt (transmission report). If you do not receive a confirmation email please contact the helpdesk or the ESMI office
  • notifications on acceptance and type of presentation (poster/talk) of your abstracts will be sent out mid/end of June 2021
  • Application for the Young Investigator Award 2021 is possible throughout the submission process

EMIM 2021 Abstract Categories

That's new:

  • The Technology section was splitted into MICRO- & MACROSCALE Technologies
  • A separated category for LUNG Imaging was added
  • There is a new category for IMAGE-GUIDED THERAPY

*Abstract Categories 2021:

1 - ONCOLOGY

1a           Understanding Tumour Biology

1b           Immuno-Oncology Imaging

1c           Imaging to Diagnose Cancer

1d           Imaging Cancer Therapy

1e           New Tools for Cancer Imaging

2 - NEUROIMAGING

2a           Structural & Functional Neuroimaging

2b           New Methods & Methodology in Neuroimaging

2c           Disease Models in Neuroimaging

2d           Neuroinflammation

3 - CARDIOVASCULAR IMAGING

3a           Cardiac Imaging

3b           Vascular Imaging

4 - new LUNG IMAGING

4             Lung Imaging

5 - IMMUNOLOGY/INFECTON

5a           Imaging Immune Response & Inflammation

5b           Imaging of Infection

6 - new IMAGE-GUIDED THERAPY

6a           Image-Guided Drug Delivery

6b           Radiotheranostics

6c           Intraoperative Image Guidance

6d           Surgical Robot Vision

7 - METABOLISM

7             Imaging Metabolism

8 - PROBE/CHEMISTRY

8a           MRI | Probe Chemistry

8b           PET/SPECT, Radionuclide, X-Ray, CT | Probe Chemistry

8c           Optical | Probe Chemistry

8d           Optoacoustic, Ultrasound, Multimodal | Probe Chemistry

9 - new MICROSCALE TECHNOLOGIES

9a           Cellular & Tissue Imaging Technologies

9b           Super-resolution & Nanoscopy Technologies

9c           Non-optical Microscopy

10 - MACROSCALE TECHNOLOGIES

10a         PET/SPECT Technologies

10b        X-Ray Technology

10c         MRI Technology

10d        MRS/Hyperpolarization Technologies

10e        Ultrasound & Optoacoustic Technologies

10f         Optical Imaging, Cerenkov-, Radio- Luminescence & Near-Infrared Technologies

10g         Multimodal & Hybrid Technology Developments

IMAGE PROCESSING

11           Image Processing & Quantification